3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
10
Neoplasm Metastasis
9
Carcinoma, Non-Small-Cell Lung
5
Recurrence
3
Prostatic Neoplasms
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Lung Neoplasms
3
Endometrial Neoplasms
3
Colorectal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Solid Tumors
2
Ovarian Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Head and Neck Neoplasms
2
Glioblastoma
2
Waldenstrom Macroglobulinemia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymoma
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Non Castrate Metastatic Prostate Cancer
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Interventions
Iodine-131
14
trametinib
9
dabrafenib
9
Thyroidectomy
9
Surgical Procedures, Operative
9
lenvatinib
8
Thyroxine
8
Magnetic Resonance Spectroscopy
8
pembrolizumab
7
Paclitaxel
7
anlotinib
6
Thyrotropin Alfa
6
selpercatinib
5
Sorafenib
5
Saline Solution
5
Radiofrequency Ablation
5
Everolimus
5
pazopanib
4
Vemurafenib
4
Sunitinib
4
Radiotherapy
4
Nivolumab
4
Fluorodeoxyglucose F18
4
Dexmedetomidine
4
Cyclophosphamide
4
Biopsy, Fine-Needle
4
Biopsy
4
Bevacizumab
4
apatinib
3
Triiodothyronine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thyroid Neoplasms
×
NVP-BKM120
×
Clear all
NCT01830504
2016-10-05
BKM120
Hospices Civils de Lyon
Phase 2
Unknown
47 enrolled